PE41096A1 - Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar - Google Patents

Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar

Info

Publication number
PE41096A1
PE41096A1 PE1995272087A PE27208795A PE41096A1 PE 41096 A1 PE41096 A1 PE 41096A1 PE 1995272087 A PE1995272087 A PE 1995272087A PE 27208795 A PE27208795 A PE 27208795A PE 41096 A1 PE41096 A1 PE 41096A1
Authority
PE
Peru
Prior art keywords
nicotine
ansia
smoking
symptoms
absence
Prior art date
Application number
PE1995272087A
Other languages
English (en)
Spanish (es)
Inventor
Satyanarayana Majeti
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE41096A1 publication Critical patent/PE41096A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
PE1995272087A 1994-06-23 1995-06-22 Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar PE41096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
PE41096A1 true PE41096A1 (es) 1996-10-08

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995272087A PE41096A1 (es) 1994-06-23 1995-06-22 Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar

Country Status (6)

Country Link
AU (1) AU2770895A (fr)
IL (1) IL114128A0 (fr)
MA (1) MA23587A1 (fr)
PE (1) PE41096A1 (fr)
WO (1) WO1996000070A1 (fr)
ZA (1) ZA955031B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828489A4 (fr) * 1996-03-13 2001-04-04 Univ Yale Traitements pour cesser de fumer impliquant l'utilisation de naltrexone et de composes associes
WO1997034605A1 (fr) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Utilisation de nicotine pour traiter une hepatopathie
EP0906089B1 (fr) * 1996-05-13 2003-08-27 Novartis Consumer Health S.A. SYSTEME DE LIBERATION BUCCAl
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
JP2003509455A (ja) 1999-04-06 2003-03-11 ダブリューエム リグリー ジュニア カンパニー 医薬チューインガム製剤
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
ES2676343T3 (es) * 2010-12-21 2018-07-18 Fertin Pharma A/S Composición de goma de mascar que comprende ácido poliacrílico reticulado
JP2023540184A (ja) * 2020-09-03 2023-09-22 ニコベンチャーズ トレーディング リミテッド 組成物及び方法
CN115590855A (zh) * 2022-10-26 2023-01-13 江南大学（Cn） 一种降低尼古丁制品中尼古丁含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (da) * 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526A (fi) * 1990-08-23 1992-02-24 Wrigley W M Jun Co Tuggummi med laog fukthalt.

Also Published As

Publication number Publication date
AU2770895A (en) 1996-01-19
WO1996000070A1 (fr) 1996-01-04
MA23587A1 (fr) 1995-12-31
IL114128A0 (en) 1995-10-31
ZA955031B (en) 1996-02-08

Similar Documents

Publication Publication Date Title
PE41096A1 (es) Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
AR012960A1 (es) Una composicion farmaceutica para utilizar en el tratamiento del sindrome de intestino irritable que comprende compuestos vainillinicos; el uso decompuestos vainillinicos, un metodo de tratamiento del sindrome de intestino irritable; un proceso para la fabricacion de dicha composicion
BR0015994A (pt) Composição de dissolução rápida com sabor doce prolongado
ES2044829T1 (es) Una composicion para el tratamiento in vivo de da\os en los tejidos producidos por isquemia u otra disfuncion proveniente de oxidacion.
US20090196834A1 (en) Tobacco alkaloid releasing chewing gum
KR970706814A (ko) 동결 건조된 온단세트론 조성물(Freeze-Dried Ondansetron Compositions)
ES2067548T3 (es) Composiciones de enmascaramiento del sabor desagradable y procedimientos para su preparacion.
PE27198A1 (es) Composiciones de confiteria
PT910339E (pt) Aerossol polar bucal
Davies The management of xerostomia: a review
HUE035266T2 (en) As a buffer, a pharmaceutical product containing trometamol for oral administration of nicotine
ES2157566T3 (es) Proceso para fabricar un chicle medicinal de sabor agradable que contenga un complejo de inclusion.
HK1081865A1 (en) Popping oral administration form
PT87348B (pt) Processo para a preparacao de uma composicao para goma de mascar com libertacao sequencial de aromas
US20110070287A1 (en) Film-Coated Compressed Chewing Gum
MX9303988A (es) Composicion de goma de mascar y metodo para perpararla.
ECSP066385A (es) Jarabe multivitamínico para niños o adultos jóvenes
PT1173181E (pt) Composicao compreendendo os inibidores da fosfodiesterase para tratar disfuncoes sexuais
BRPI0611420A2 (pt) produtos de confeitaria para o tratamento de boca seca
Lapin Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol
JP2019514990A5 (fr)
ES2164753T3 (es) Tabletas organolepticamente estables para la limpieza de dentaduras.
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
PE20011221A1 (es) Metodo para reducir o eliminar el tabaquismo
DE1901277A1 (de) Mittel zur Kompensation uebermaessigen Zigarettenkonsums

Legal Events

Date Code Title Description
FD Application declared void or lapsed